The New York City Economic Development Corporation began construction on the $454 million NYC Public Health Laboratory in June of 2022. Strategically sited adjacent to Harlem Hospital, the 240,000-sf building will provide the Department of Health and Mental Hygiene with sophisticated infrastructure for the detection and mitigation of infectious diseases and pathogens.
Albany College of Pharmacy and Health Sciences has acquired an existing life sciences facility to house the Center for Biopharmaceutical Education and Training. Sited adjacent to the school's campus in Albany, New York, the 154,000-sf structure is uniquely designed for biomedical research with over 60,000 sf of BSL-2 and BSL-3 laboratory space. The five-story building will be renovated to create dedicated gene therapy labs, mammalian cell labs, teaching wet labs, biopharmaceutical pilot plants, and fermentation and downstream processing facilities.
The Sixth Edition of the Biosafety in Microbiological and Biomedical Laboratories (BMBL) manual emphasizes the importance of risk assessment and management, communication among all stakeholders, comprehensive procedures to report accidents and exposures, and a new focus on biocontainment of pathogens affecting agricultural animals. First published in 1984, the BMBL still serves as the cornerstone of biosafety practices for the safe conduct of research throughout the world.
North Carolina State University dedicated the $160.2 million Plant Sciences Building in Raleigh in April of 2022. Designed by Flad Architects, the 185,000-sf facility enables academic, government, and industry researchers to develop innovative solutions for global agricultural challenges.
Southern Research will begin construction in mid-2022 on an $84 million biotechnology center in Birmingham, Ala. Providing crucial biocontainment capacity for the study of infectious diseases, the 80,000-sf building will enhance pandemic preparedness efforts with BSL-3 laboratories spanning 7,500 sf. The five-level project will also include structural biology labs, high-throughput screening facilities, and a STEM education center.
Amgen broke ground in March of 2022 on a $550 million biomanufacturing center in Holly Springs, N.C. Accommodating the company's FleXBatch platform, the project will integrate traditional methods for drug substance production with single-use bioprocessing technologies to create a hybrid facility with unrivaled operational efficiencies. The next-generation plant will manufacture advanced therapeutics for the treatment of cardiovascular disease, cancer, osteoporosis, inflammation, and other conditions.
The University of Wyoming opened the $100 million Science Initiative Building in March of 2022 in Laramie. Designed by GSG Architecture and Perkins&Will, the 153,000-sf structure will enhance interaction among multiple disciplines by collocating researchers into a single complex with shared core facilities. Located on the first floor to mitigate vibration, the Center for Advanced Scientific Instrumentation provides electron microscopes, an X-ray refractometer, a mass spectrometer, and micro CT scanners.
Vibalogics completed construction in December of 2021 on a $150 million virotherapy facility in Boxborough, Mass. Sited on 145 acres, the next-generation manufacturing plant supports commercial production of oncolytic viruses, viral vector vaccines, and viral vector gene therapy products. The highly flexible structure incorporates 2,000-liter bioreactors, multiple cGMP production suites, offices, warehouse space, and labs for research, development, and quality control.
Pfizer opened a $68.5 million clinical manufacturing facility in December of 2021 in Durham. Accommodating the company's BioTherapeutics Pharmaceutical Sciences division, the 85,500-sf project will support the creation of gene therapies for the treatment of hemophilia A, hemophilia B, Duchenne muscular dystrophy, and other diseases. Leveraging single-use bioreactors to enable scalable expansion over time, the structure provides multiple drug substance suites, analytical and microbiology labs, and areas for manufacturing and filling.
Washington University School of Medicine will break ground in spring of 2022 on a $150 million vertical expansion of the Steven & Susan Lipstein BJC Institute of Health in St. Louis. Designed by Lawrence Group to promote collaboration and discovery, the six-story, 160,000-sf addition will provide 103,000 sf of biomedical research space and a 7,900-sf BSL-3 laboratory for the study of infectious diseases such as SARS-CoV-2 and tuberculosis.
Texas Biomedical Research Institute broke ground in December of 2021 on a $15 million nonhuman primate complex in San Antonio. Part of the Southwest National Primate Research Center, the four-building expansion will feature three large structures offering indoor and outdoor housing environments. An 18,000-sf animal care facility will provide a state-of-the-art veterinary clinic, pathology labs, and a staff meeting hub.
Pennsylvania State University opened the $98.5 million Animal, Veterinary and Biomedical Sciences Building in December of 2021 in University Park. Designed by HOK, the 105,000-sf facility provides the College of Agricultural Sciences with a state-of-the-art vivarium, a general-purpose classroom capable of accommodating 100 students, a 48-seat seminar room, and faculty offices.
BeiGene is planning to break ground in 2022 on a pharmaceutical manufacturing and research center in Hopewell, N.J. Located on the Princeton West Innovation Campus, the integrated complex will provide 400,000 sf of dedicated space for commercial-stage production of innovative cancer therapies. Offering up to 16,000 liters of biologics capacity, the facility will also include clinical R&D labs and collaborative office environments. IPS is the architect and engineer for the project, which will be built by DPR Construction.
Rocky Mountain Laboratories began construction in December of 2021 on a $93 million animal research vivarium in Hamilton, Mont. Accelerating the detection and mitigation of emerging infectious diseases, the 120,000-sf structure will provide climate-controlled environments for rodents, ticks, bats, and other species. The technology-rich building will also house an analytical lab and collaborative workspaces for researchers and staff.
Moderna is partnering with Alexandria Real Estate Equities to create a 462,000-rsf headquarters and research facility at the Alexandria Center development at One Kendall Square. Accelerating the discovery and development of mRNA vaccines and therapeutics, the collaborative structure will feature leading-edge R&D labs, sophisticated offices, and engaging gathering spaces.
